Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study.

Messa E, Gioia D, Masiera E, Castiglione A, Ceccarelli M, Salvi F, Danise P, Sanna A, Allione B, Balleari E, Poloni A, Cametti G, Ferrero D, Tassara R, Finelli C, Bonferroni M, Musto P, Saglio G, Levis A, Santini V.

Haematologica. 2019 Jan;104(1):e4-e8. doi: 10.3324/haematol.2017.183590. Epub 2018 Aug 3. No abstract available.

2.

Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.

Park S, Hamel JF, Toma A, Kelaidi C, Thépot S, Campelo MD, Santini V, Sekeres MA, Balleari E, Kaivers J, Sapena R, Götze K, Müller-Thomas C, Beyne-Rauzy O, Stamatoullas A, Kotsianidis I, Komrokji R, Steensma DP, Fensterl J, Roboz GJ, Bernal T, Ramos F, Calabuig M, Guerci-Bresler A, Bordessoule D, Cony-Makhoul P, Cheze S, Wattel E, Rose C, Vey N, Gioia D, Ferrero D, Gaidano G, Cametti G, Pane F, Sanna A, Germing U, Sanz GF, Dreyfus F, Fenaux P.

J Clin Oncol. 2017 May 10;35(14):1591-1597. doi: 10.1200/JCO.2016.71.3271. Epub 2017 Mar 28.

PMID:
28350519
3.

A Deep Look Into Erionite Fibres: an Electron Microscopy Investigation of their Self-Assembly.

Matassa R, Familiari G, Relucenti M, Battaglione E, Downing C, Pacella A, Cametti G, Ballirano P.

Sci Rep. 2015 Nov 16;5:16757. doi: 10.1038/srep16757.

4.

Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?

Santini V, Schemenau J, Levis A, Balleari E, Sapena R, Adès L, Guerci A, Beyne-Rauzy O, Gourin MP, Cheze S, Stamatoullas A, Sanna A, Gioia D, Cametti G, Ferrero D, Raffoux E, Rose C, Poloni A, Prebet T, Legros L, Natarajan-Amé S, Fenaux P, Germing U, Dreyfus F, Park S.

Blood. 2013 Sep 26;122(13):2286-8. doi: 10.1182/blood-2013-07-512442. No abstract available.

5.

Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes.

Falco P, Levis A, Stacchini A, Ciriello MM, Geuna M, Notari P, Omedè P, Pautasso M, Prato G, Strola G, Gioia D, Bonferroni M, Cametti G, Ferrero D, Freilone R, Gaidano G, Marinone C, Marmont F, Pollio B, Salvi F, Saglio G, Girotto M; Piedmont MDS Registry--Italy.

Eur J Haematol. 2011 Nov;87(5):409-18. doi: 10.1111/j.1600-0609.2011.01676.x. Epub 2011 Aug 11.

PMID:
21711395
6.

The effects of exposure to moderate altitude on cardiovascular autonomic function in normal subjects.

Veglio M, Maule S, Cametti G, Cogo A, Lussiana L, Madrigale G, Pecchio O.

Clin Auton Res. 1999 Jun;9(3):123-7.

PMID:
10454057
7.

[Variability of the response to recombinant human erythropoietin in patients undergoing hemodialysis treatment].

Baroni A, Airoldi G, Agliata S, Fortina F, Ragazzoni E, Cavagnino A, De Nigris A, Cametti G, Ferrero D, Fortina A.

Minerva Urol Nefrol. 1991 Jul-Sep;43(3):131-5. Italian.

PMID:
1817334
8.

Predictive value of the early response to chemotherapy in high-risk stages II and III Hodgkin's disease.

Levis A, Vitolo U, Ciocca Vasino MA, Cametti G, Urgesi A, Bertini M, Canta M, Monetti U, Bosio C, Jayme A, et al.

Cancer. 1987 Oct 15;60(8):1713-9.

PMID:
3651998
9.

Peripheral erythroid precursor and prognosis in chronic granulocytic leukemia.

Levis A, Marmont F, Ciocca Vasino MA, Jayme A, Infelise V, Cametti G, Canta M, Resegotti L.

Cancer. 1986 Jul 15;58(2):229-33.

PMID:
3459569

Supplemental Content

Loading ...
Support Center